SCOPUS 정보 검색 플랫폼

Volumn 19, Issue 4, 2001, Pages 311-315

Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A Southwest Oncology Group Phase II study

(7) Samlowski, Wolfram E a Gundacker, Holly b Kuebler, J Philip c Giguere, Jeffrey K d Mills, Glenn M e Schuller, David E f Ensley, John F g

a UNIVERSITY OF UTAH (United States)

b SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER (United States)

c Columbus CCOP ^* (United States)

d Greenville CCOP (United States)

e LOUISIANA STATE UNIV MEDICAL CENTER (United States)

f OHIO STATE UNIVERSITY (United States)

g WAYNE STATE UNIVERSITY (United States)

Author keywords

Gemcitabine; Phase II trial; Squamous cell carcinoma

Indexed keywords

GEMCITABINE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEAD AND NECK CANCER; HEPATITIS; HUMAN; LIVER FAILURE; LIVER METASTASIS; MALE; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT CANCER; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; DEOXYCYTIDINE; DRUG EVALUATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RIBONUCLEOTIDE REDUCTASES; SURVIVAL RATE;

EID: 0034861302 PISSN: 01676997 EISSN: None Source Type: Journal
DOI: 10.1023/A:1010657609609 Document Type: Article

Times cited : (28)

References (16)

1
- 0001091070
- Tumors of the nasal cavity and paranasal sinuses, nasopharynx, oral cavity and oropharynx
- De Vita VT, Hellman S, Rosenberg SA. Philadelphia: Lippincott-Raven
- (1997) Cancer: Principles and practice of oncology. 5 ed. , pp. 741-803
- Schantz, S.P.¹ Harrison, L.B.² Forastiere, A.A.³

2
- 0021152550
- Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck
- (1984) Cancer , vol.53 , pp. 1819-1824
- Kish, J.A.¹ Weaver, A.² Jacobs, J.³ Cummings, G.⁴ Al-Sarraf, M.⁵

3
- 0026645077
- Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study
- (1992) J Clin Oncol , vol.10 , pp. 1245-1251
- Forastiere, A.A.¹ Metch, B.² Schuller, D.E.³ Ensley, J.F.⁴ Hutchins, L.F.⁵ Triozzi, P.⁶ Kish, J.⁷ McClure, S.⁸ Von Feldt, E.⁹ Williamson, S.K.¹⁰ Von Hoff, D.D.¹¹

4
- 0026569931
- A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck
- (1992) J Clin Oncol , vol.10 , pp. 257-263
- Jacobs, C.¹ Lyman, G.² Velez Garcia, E.³ Sridhar, K.S.⁴ Knight, W.⁵ Hochster, H.⁶ Goodnough, L.T.⁷ Mortimer, J.E.⁸ Einhorn, L.H.⁹ Schacter, L.¹⁰

5
- 6844236387
- Phase III trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer
- Head and Neck Interferon Cooperative Study Group
- (1998) J Clin Oncol , vol.16 , pp. 1054-1059
- Schrijvers, D.¹ Johnson, J.² Jiminez, U.³ Gore, M.⁴ Kosmidis, P.⁵ Szpirglas, H.⁶

6
- 0028799108
- Gemcitabine: Metabolism, mechanisms of action, and self-potentiation
- (1995) Semin Oncol , vol.22 , pp. 3-10
- Plunkett, W.¹ Huang, P.² Xu, Y.Z.³ Heinemann, V.⁴ Grunewald, R.⁵ Gandhi, V.⁶

7
- 0029060757
- Fludarabine- and gemcitabine-induced apoptosis: Incorporation of analogs into DNA is a critical event
- (1995) Cancer Chemother Pharmacol , vol.36 , pp. 181-188
- Huang, P.¹ Plunkett, W.²

8
- 0025325071
- Evaluation of the antitumor activity of gemcitabine (2′,2′-difluoro-2′-deoxycytidine)
- (1990) Cancer Res , vol.50 , pp. 4417-4422
- Hertel, L.W.¹ Boder, G.B.² Kroin, J.S.³ Rinzel, S.M.⁴ Poore, G.A.⁵ Todd, G.C.⁶ Grindey, G.B.⁷

9
- 0026640498
- Activity of 2′,2′-difluorodeoxycytidine (gemcitabine) against human tumor colony forming units
- (1992) Anti-Cancer Drugs , vol.3 , pp. 143-146
- Hanauske, A.R.¹ Degen, D.² Marshall, M.H.³ Hilsenbeck, S.G.⁴ Grindey, G.B.⁵ Von Hoff, D.D.⁶

10
- 0004062093
- Indianapolis: Eli Lilly and Co.
- (1993) Gemcitabine HCl (LY188011 HCl): Clinical Investigation Brochure

11
- 0027946936
- Weekly gemcitabine in advanced or metastatic solid tumors. A clinical phase I study
- (1994) Invest New Drugs , vol.12 , pp. 111-119
- Pollera, C.F.¹ Ceribelli, A.² Crecco, M.³ Calabresi, F.⁴

12
- 0001303555
- Prognostic factors in a randomized trial of gemcitabine (GEM) versus 5-FU as first-line therapy in advanced pancreatic cancer and in pancreatic cancer patients failing 5-FU who received gemcitabine as a palliative therapy
- (1996) Proc Am Soc Clin Oncol , vol.15 , pp. 506
- Niyikiza, C.¹ Andersen, J.S.² Tarassoff, P.G.³ Rothenberg, M.L.⁴ Seitz, D.E.⁵ Nelson, R.L.⁶ Moore, M.⁷ Storniolo, A.M.⁸

13
- 0028799915
- Advanced breast cancer: A phase II trial with gemcitabine
- (1995) J Clin Oncol , vol.13 , pp. 2731-2736
- Carmichael, J.¹ Possinger, K.² Phillip, P.³ Beykirch, M.⁴ Kerr, H.⁵ Walling, J.⁶ Harris, A.L.⁷

14
- 0029033703
- Gemcitabine in non-small cell lung cancer
- (1995) Lung Cancer , vol.12 , Issue.SUPPL. 1
- Sorensen, J.B.¹

15
- 0028020890
- Phase II study of gemcitabine (2′,2′-difluorodeoxycytidine) in previously treated ovarian cancer patients
- (1994) J Natl Cancer Inst , vol.86 , pp. 1530-1533
- Lund, B.¹ Hansen, O.P.² Theilade, K.³ Hansen, M.⁴ Neijt, J.P.⁵

16
- 0028241688
- A phase II study of gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck
- EORTC Early Clinical Trials Group
- (1994) Ann Oncol , vol.5 , pp. 543-547
- Catimel, G.¹ Vermorken, J.B.² Clavel, M.³ De Mulder, P.⁴ Judson, I.⁵ Sessa, C.⁶ Piccart, M.⁷ Bruntsch, U.⁸ Verweij, J.⁹ Wanders, J.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.